# New Glaucoma clinical trials: 167 posted since Nov 2024

Updated November 5, 2026.

167 clinical studies in glaucoma were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 37 have an industry sponsor and 110 are recruiting or about to. The newest, NCT07917741, was posted on November 5, 2026: AI-Assisted vs Conventional Teleglaucoma Referral (University of Southern California).

## The full list

New Glaucoma clinical trials: 167 rows for $8.35, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 10 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/glaucoma

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 167
- Industry sponsored: 37
- Recruiting or not yet: 110
- Latest posted: November 5, 2026

## Newest trials

The newest 100 of 167, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07917741 | AI-Assisted vs Conventional Teleglaucoma Referral | University of Southern California | Not applicable | Not yet recruiting | Glaucoma | 1,386 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917741) |
| November 3, 2026 | NCT07913074 | A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With... | Tavo Biotherapeutics | Phase 2 | Recruiting | Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT) | 96 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913074) |
| November 2, 2026 | NCT07910955 | Effects of Balance Training in Individuals With Glaucoma | Kanuni Sultan Suleyman Training and Research Hospital | Not applicable | Recruiting | Glaucoma | 50 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910955) |
| October 30, 2026 | NCT07907055 | PAUL® Glaucoma Implant Safety and Effectiveness Study | Clinical Research Consultants, Inc. | Not applicable | Not yet recruiting | Refractory Glaucoma | 65 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907055) |
| October 23, 2026 | NCT07891910 | Iopidine to Decrease Intraocular Pressure Rise After Injections | Retina Consultants of Delmarva | Phase 4 | Not yet recruiting | Macular Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, Glaucoma | 120 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891910) |
| October 23, 2026 | NCT07891182 | VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study | University of Miami | Phase 2 | Not yet recruiting | Glaucoma | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891182) |
| October 9, 2026 | NCT07869108 | Trabeculectomy Versus MicroShunt Implantation in Glaucoma Surgery (TIGER) | Oslo University Hospital | Not applicable | Not yet recruiting | Glaucoma | 100 | Norway | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869108) |
| October 6, 2026 | NCT07861243 | Unravelling the Effects of Nicotinamide/Pyrroloquinolone Quinone /Citicoline/Homotaurine Fixed Combination on Contrast Sensitivity, Quality... | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | Not applicable | Completed | Glaucoma | 44 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861243) |
| October 1, 2026 | NCT07853469 | Optical Coherence Tomography Findings Associated With the Glaucoma-periodontitis Stage | Recep Tayyip Erdogan University Training and Research Hospital | Observational | Completed | Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder), Periodontitis | 66 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853469) |
| September 29, 2026 | NCT07847073 | Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients | Brett King | Phase 4 | Recruiting | Open Angle Glaucoma (OAG), Glaucoma | 13 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847073) |
| September 28, 2026 | NCT07845357 | Switching From Preserved Glaucoma Therapy to Preservative-Free ZOLYMBUS | Southern College of Optometry | Phase 4 | Not yet recruiting | Eye Drops Self-instillation, Glaucoma, Dry Eye | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845357) |
| September 25, 2026 | NCT07841912 | Ocular Surface Disease in Glaucoma Patients on Long-Term Therapy | Assiut University | Observational | Not yet recruiting | Glaucoma, Ocular Surface Disease, Dry Eye | 55 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841912) |
| September 21, 2026 | NCT07830017 | Combined Nasal Goniotomy-Temporal Trabeculotomy Versus Temporal Trabeculotomy for Management of Primary Congenital Glaucoma | Zagazig University | Not applicable | Completed | Primary Congenital Glaucoma | 21 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830017) |
| September 17, 2026 | NCT07824232 | Visual Function and Exercise in Glaucoma Patients | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Observational | Not yet recruiting | Glaucoma, Exercise | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824232) |
| September 15, 2026 | NCT07820709 | Artificial Intelligence for Staging Glaucoma Severity: A Comparison With an Eye Specialist Using Visual Field Tests | University of Salerno | Observational | Completed | Glaucoma and Ocular Hypertension | 50 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820709) |
| September 14, 2026 | NCT07816692 | iDose TR Administration in an Office-Based Surgery Setting | Glaukos Corporation | Observational | Recruiting | Open Angle Glaucoma (OAG), Ocular Hypertension (OHT) | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816692) |
| September 4, 2026 | NCT07804277 | Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT) | Tomey Corporation | Observational | Recruiting | Glaucoma | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804277) |
| September 3, 2026 | NCT07803536 | Effect of Late Ripcord Removal From Glaucoma Drainage Device | Duke University | Not applicable | Recruiting | GLAUCOMA 1, OPEN ANGLE, D (Disorder), Glaucoma | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803536) |
| September 3, 2026 | NCT07802769 | Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma | University Hospital, Bordeaux | Not applicable | Recruiting | Glaucoma | 100 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802769) |
| August 28, 2026 | NCT07793474 | Eye Patient Adherence and Compliance Study | St. Joseph's Healthcare Hamilton | Not applicable | Not yet recruiting | Glaucoma Medication Adherence, Glaucoma Patients | 189 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793474) |
| August 24, 2026 | NCT07780916 | Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management | Wuerzburg University Hospital | Observational | Recruiting | Glaucoma, Glaucoma Patient, GLAUCOMA 1, OPEN ANGLE, D (Disorder), Glaucoma Following Surgery, Glaucoma Eye | 200 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780916) |
| August 20, 2026 | NCT07775898 | Behavioural Test for Early Glaucoma | McGill University Health Centre/Research Institute of the McGill University Health Centre | Observational | Not yet recruiting | Glaucoma Diagnosis | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775898) |
| August 18, 2026 | NCT07771699 | Cross-modal Neuromodulation to Improve Balance and Cognition in Older Adults With Glaucoma: A Randomized Trial of Cerebellar Transcranial... | The Hong Kong Polytechnic University | Not applicable | Recruiting | Glaucoma | 36 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771699) |
| August 18, 2026 | NCT07770685 | A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage | Astellas Pharma Global Development, Inc. | Phase 1/2 | Recruiting | Glaucoma | 156 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770685) |
| August 18, 2026 | NCT07769463 | Impact of Meditation on Reducing Stress in Glaucoma Patients: An Electronic Feasibility Study | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Not applicable | Not yet recruiting | Glaucoma | 158 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769463) |
| August 14, 2026 | NCT07765147 | Evaluating iCare COMPASS as a Visual Field Diagnostic Tool | Indiana University | Not applicable | Completed | GLAUCOMA 1, OPEN ANGLE, D (Disorder) | 28 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765147) |
| August 13, 2026 | NCT07763288 | Prevalence of Glaucoma and Normative Data of Ocular Biometry in Elderly Population in Bangkok | Siriraj Hospital | Observational | Completed | Glaucoma, Glaucoma, Open-Angle, Glaucoma, Suspect, Glaucoma, Angle-Closure, Cataract, Blind Eye | 1,470 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763288) |
| August 13, 2026 | NCT07762053 | Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor Tonometer | EyeCBetter Corporation | Not applicable | Active not recruiting | Elevated Intraocular Pressure (IOP) | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762053) |
| August 11, 2026 | NCT07758569 | Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With... | Democritus University of Thrace | Observational | Recruiting | Glaucoma | 2,000 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758569) |
| August 10, 2026 | NCT07755761 | Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomized Controlled Trial | Benha University | Not applicable | Recruiting | Glaucoma, Trabeculectomy, Innovative Procedures | 116 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755761) |
| August 10, 2026 | NCT07755748 | Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives | University of California, San Francisco | Not applicable | Recruiting | Screening | 2,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755748) |
| August 10, 2026 | NCT07754201 | VividFlo System Validation Study | VividWhite Pty Ltd | Not applicable | Not yet recruiting | Glaucoma | 10 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754201) |
| August 3, 2026 | NCT07741812 | Testing a Reading Module to Improve Reading Skills and Quality of Life in Glaucoma Patients | Universiti Sains Malaysia | Not applicable | Not yet recruiting | Primary Open Angle Glaucoma (POAG), Juvenile Open Angle Glaucoma, Normotensive Glaucoma, Primary Angle Closure Glaucoma | 100 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741812) |
| July 31, 2026 | NCT07739784 | This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using... | McGill University Health Centre/Research Institute of the McGill University Health Centre | Observational | Recruiting | Glaucoma | 352 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739784) |
| July 29, 2026 | NCT07733453 | Baerveldt Versus Paul Study | University of Sydney | Phase 4 | Not yet recruiting | Glaucoma | 150 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733453) |
| July 29, 2026 | NCT07733388 | The Effectiveness Of Home-Based Circuit Training On Eye Pressure And Eye Nerve Structures In Patients With Glaucoma | Universiti Sains Malaysia | Not applicable | Not yet recruiting | Glaucoma | 60 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733388) |
| July 28, 2026 | NCT07730424 | VW-50 Feasibility Study | Melbourne Eye Specialists | Not applicable | Completed | Glaucoma | 10 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730424) |
| June 29, 2026 | NCT07674069 | World Sight Foundation Field Machine (WSFFM) Pilot | Buckinghamshire Healthcare NHS Trust | Not applicable | Recruiting | Glaucoma | 100 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07674069) |
| June 25, 2026 | NCT07668193 | GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening | Fondazione G.B. Bietti, IRCCS | Not applicable | Not yet recruiting | Glaucoma | 1,200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668193) |
| June 24, 2026 | NCT07664943 | The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence | Universal Adherence LLC | Not applicable | Not yet recruiting | Glaucoma, Medication Adherence | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07664943) |
| June 11, 2026 | NCT07643077 | CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE) | University of Ioannina | Observational | Active not recruiting | Glaucoma | 45 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643077) |
| June 11, 2026 | NCT07641296 | Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With... | SpyGlass Pharma, Inc. | Phase 1 | Not yet recruiting | Glaucoma, Ocular Hypertension | 24 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641296) |
| June 3, 2026 | NCT07623434 | Comparison of Safety and Efficacy of Hydrus and iStent Combined With Phacoemulsyfication in Open Angle Glaucoma Patients Long-Term Follow-Up | Military Institute od Medicine National Research Institute | Not applicable | Completed | Glaucoma | 65 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623434) |
| June 2, 2026 | NCT07619482 | Topical Insulin for Glaucoma (TING2) | Stanford University | Phase 1/2 | Enrolling by invitation | Open Angle Glaucoma, Primary Open Angle Glaucoma, Low Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma | 90 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619482) |
| May 22, 2026 | NCT07604428 | Intraocular Pressure During Static Apnea | University Hospital Olomouc | Observational | Completed | Glaucoma, Intraocular Pressure, Apnea | 40 | Czechia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604428) |
| May 18, 2026 | NCT07592988 | Tear Interleukin Biomarkers After Glaucoma Treatment | Kazakh Eye Research Institute | Not applicable | Completed | Glaucoma | 24 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592988) |
| May 18, 2026 | NCT07592923 | Morphometric Markers of the Effectiveness of Micropulse Cyclophotocoagulation | Kazakh Eye Research Institute | Not applicable | Completed | Glaucoma | 20 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592923) |
| May 14, 2026 | NCT07588152 | Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension | Indiana University | Phase 4 | Recruiting | Glaucoma, Ocular Hypertension | 50 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588152) |
| May 12, 2026 | NCT07580014 | Choroidal and Retinal Features in PACD and POAG on OCT and OCTA | Zhongshan Ophthalmic Center, Sun Yat-sen University | Observational | Recruiting | Glaucoma, OCTA, Choroid | 132 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580014) |
| April 29, 2026 | NCT07555574 | Defining Retinal Structures Using Hyperspectral Retinal Imaging | Center for Eye Research Australia | Not applicable | Recruiting | Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Diseases, Healthy Volunteers | 1,000 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555574) |
| April 28, 2026 | NCT07554937 | Blinking Exercise Study | St. Joseph's Healthcare Hamilton | Not applicable | Not yet recruiting | Dry Eye Disease (DED), Glaucoma | 45 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554937) |
| April 24, 2026 | NCT07550712 | A Study to Evaluate the Clinical Performance of VeriSee GLC for Screening of Glaucoma Suspect Using Color Fundus Images | Acer Medical Inc. | Observational | Completed | Glaucoma | 773 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550712) |
| April 15, 2026 | NCT07531199 | Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device | Hôpital Privé de la Baie | Not applicable | Recruiting | Glaucoma | 192 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531199) |
| April 3, 2026 | NCT07510087 | Glaucoma Related Quality of Life | Marc Toeteberg-Harms | Observational | Recruiting | Glaucoma | 5,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510087) |
| March 27, 2026 | NCT07497815 | Artificial Intelligence-assisted Diagnosis in Ophthalmology | Marisse Masis-Solano | Observational | Not yet recruiting | Macular Degeneration, Diabetic Retinopathy (DR), Glaucoma, Keratoconus, Cataract | 15,000 | Costa Rica | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497815) |
| March 27, 2026 | NCT07495852 | Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant | Glaukos Corporation | Phase 3 | Recruiting | Glaucoma | 510 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495852) |
| March 23, 2026 | NCT07488234 | Impact of a Glaucoma Awareness Program on Treatment Adherence | Seva Canada Society | Not applicable | Not yet recruiting | Glaucoma | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07488234) |
| March 18, 2026 | NCT07480603 | Pilot Study on a New Self Adjustable Glaucoma Drainage Device | Rheon Medical SA | Phase 1 | Active not recruiting | Glaucoma | 10 | Senegal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07480603) |
| March 12, 2026 | NCT07465913 | Rocklatan vs Latanoprost Post-DSLT | Eye Centers of Southeast Texas | Phase 4 | Recruiting | Glaucoma | 36 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465913) |
| March 10, 2026 | NCT07462000 | Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract | Military Institute od Medicine National Research Institute | Not applicable | Recruiting | Primary Open-Angle Glaucoma (POAG), Cataract | 40 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462000) |
| March 10, 2026 | NCT07460791 | Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years | Johannes Gutenberg University Mainz | Observational | Recruiting | Glaucoma | 200 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07460791) |
| March 6, 2026 | NCT07455786 | Modified Trabeculectomy After Failure of Combined Phaco With GATT | Assiut University | Not applicable | Recruiting | Glaucoma | 20 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07455786) |
| February 24, 2026 | NCT07428668 | Change in IOP Fluctuation After DSLT | Ophthalmology Associates, Fort Worth | Observational | Recruiting | Glaucoma | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428668) |
| February 23, 2026 | NCT07425535 | Optic Nerve Head Strain in Non-glaucoma Subjects | Johns Hopkins University | Early phase 1 | Recruiting | Glaucoma | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07425535) |
| February 23, 2026 | NCT07425496 | To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving... | The New York Eye & Ear Infirmary | Observational | Recruiting | Cataract, Glaucoma | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07425496) |
| February 13, 2026 | NCT07409077 | Efficacy of Biofeedback Training for Glaucoma | University Health Network, Toronto | Not applicable | Recruiting | Glaucoma, Biofeedback Training | 70 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07409077) |
| February 13, 2026 | NCT07408154 | Direct vs Standard SLT for Glaucoma: A Noninferiority Trial | Medical University of South Carolina | Not applicable | Recruiting | Open-angle Glaucoma (OAG), Ocular Hypertension (OHT) | 172 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408154) |
| February 10, 2026 | NCT07400926 | Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg | Glaukos Corporation | Observational | Recruiting | Open Angle Glaucoma (OAG), Ocular Hypertension (OH) | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400926) |
| January 23, 2026 | NCT07364929 | Altered Non-Visual Photoreception in Patients With Glaucoma: Impacts on Sleep, Alertness, Mood, and Cognition | National University of Singapore | Not applicable | Recruiting | Glaucoma | 120 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07364929) |
| January 22, 2026 | NCT07359547 | Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt | Universitaire Ziekenhuizen KU Leuven | Not applicable | Recruiting | GLAUCOMA 1, OPEN ANGLE, D (Disorder) | 166 | Belgium, Germany, Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359547) |
| January 21, 2026 | NCT07354516 | Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension | Qlaris Bio, Inc. | Phase 2/3 | Completed | OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension | 64 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354516) |
| January 21, 2026 | NCT07354477 | Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation | Qlaris Bio, Inc. | Phase 2 | Completed | Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG), Normal Tension Glaucoma (NTG) | 9 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354477) |
| January 21, 2026 | NCT07354009 | Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Glaucoma | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354009) |
| January 20, 2026 | NCT07350304 | Comparison of Two OCT Device RNFL and GCIPL Measurements in Mild, Moderate, and Severe Glaucoma | Twin Cities Eye Consultants | Observational | Completed | Glaucoma | 141 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07350304) |
| January 20, 2026 | NCT07350200 | XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications During a Long-Term Follow-Up | Military Institute od Medicine National Research Institute | Not applicable | Completed | Glaucoma | 150 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07350200) |
| January 14, 2026 | NCT07341763 | Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment | University of Waterloo | Not applicable | Recruiting | Retinitis Pigmentosa (RP), Rod Cone Dystrophy, Visually Impaired Persons, Peripheral Visual Field Defect of Both Eyes... | 20 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341763) |
| January 8, 2026 | NCT07327242 | Effectiveness of a Large Language Model-Based Educational Tool on Visual Field Test Reliability in Glaucoma Patients | Stanford University | Not applicable | Enrolling by invitation | Glaucoma, Eye Disorders, Visual Fields, Visual Field Tests | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327242) |
| January 8, 2026 | NCT07325552 | iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment | Medical University of Bialystok | Not applicable | Recruiting | Open Angle Glaucoma (OAG) | 100 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325552) |
| January 7, 2026 | NCT07322965 | Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma | Institut Catala de Retina | Not applicable | Recruiting | Glaucoma, Primary Open Angle Glaucoma (POAG), Neuroprotection | 108 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322965) |
| January 6, 2026 | NCT07318428 | AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma | Inje University | Not applicable | Completed | Diabetic Retinopathy, Age Related Macular Degeneration, Retinal Vein Occlusion, Glaucoma, Glaucoma Suspect | 10 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318428) |
| December 24, 2025 | NCT07303257 | Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options | Hospices Civils de Lyon | Observational | Recruiting | Glaucoma Eye, Open-angle Glaucoma, Closed-Angle Glaucoma, Pseudo Exfoliative Syndrome, Pigmentary Glaucoma | 132 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303257) |
| December 24, 2025 | NCT07300852 | DSLT in Normal Tension Glaucoma (NTG) Asian Eyes | Ngoc Nguyen Inc. | Not applicable | Not yet recruiting | Normal Tension Glaucoma (NTG), Glaucoma, Open Angle Glaucoma (OAG), Glaucoma, Open Angle | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300852) |
| December 23, 2025 | NCT07298356 | Automated Applanation Tonometry - Updated | Duke University | Not applicable | Recruiting | Glaucoma, Glaucoma, Suspect | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298356) |
| December 16, 2025 | NCT07285616 | Optimizing Graft Selection in Glaucoma Surgery: A Comparative Study of Sclera, Pericardium, and Corneal Tissue | University of Alberta | Not applicable | Not yet recruiting | Glaucoma | 180 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285616) |
| November 25, 2025 | NCT07249307 | High-throughput Large-model-based AI-assisted Diagnosis Using OCT | Peking Union Medical College Hospital | Observational | Not yet recruiting | Diabetic Retinopathy (DR), Retinal Vein Occlusion (RVO), Age-Related Macular Degeneration (AMD), Pathologic Myopia... | 2,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249307) |
| November 24, 2025 | NCT07243665 | Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program | Singapore Eye Research Institute | Not applicable | Recruiting | Glaucoma | 1,040 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243665) |
| November 4, 2025 | NCT07224542 | Smart Soft Contact Lenses for Monitoring Glaucoma | Indiana University | Not applicable | Enrolling by invitation | Glaucoma | 120 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224542) |
| October 24, 2025 | NCT07220876 | Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma | Avisi Technologies Inc. | Not applicable | Recruiting | Open Angle Glaucoma (OAG) | 165 | South Africa, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220876) |
| October 20, 2025 | NCT07218796 | Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol... | SpyGlass Pharma, Inc. | Phase 3 | Recruiting | Cataract, Glaucoma, Ocular Hypertension | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218796) |
| October 20, 2025 | NCT07218783 | Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol... | SpyGlass Pharma, Inc. | Phase 3 | Recruiting | Cataract, Glaucoma, Ocular Hypertension | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218783) |
| October 16, 2025 | NCT07217678 | Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use | University of Miami | Phase 4 | Recruiting | Glaucoma, Open-Angle Glaucoma, Ocular Hypertension, Glaucoma Suspect | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217678) |
| October 14, 2025 | NCT07216677 | A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases | Interstat LLC | Observational | Active not recruiting | Glaucoma, AMD, Diabetic Retinopathy (DR) | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216677) |
| October 7, 2025 | NCT07209410 | Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat... | Insight Eyecare Specialties, Inc. dba Vision Source Eyecare, | Phase 4 | Recruiting | Glaucoma | 35 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209410) |
| September 16, 2025 | NCT07174401 | Rocklatan Retinal Perfusion OCT Study | Oregon Health and Science University | Phase 4 | Not yet recruiting | Glaucoma | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174401) |
| September 11, 2025 | NCT07168902 | Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension | Bausch & Lomb Incorporated | Phase 2 | Completed | Glaucoma | 252 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07168902) |
| September 9, 2025 | NCT07163676 | Is There a Response of Glaucoma to Baduanjin Exercise in Elders? | Cairo University | Not applicable | Recruiting | Glaucoma | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07163676) |
| September 4, 2025 | NCT07154810 | Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost... | SpyGlass Pharma, Inc. | Observational | Active not recruiting | Glaucoma, Cataract, Ocular Hypertension | 23 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154810) |
| September 4, 2025 | NCT07154797 | Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild... | SpyGlass Pharma, Inc. | Not applicable | Completed | Cataract, Ocular Hypertension, Glaucoma | 24 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154797) |
| September 4, 2025 | NCT07153588 | Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital. | Bacha Khan Medical College | Observational | Completed | Glaucoma | 379 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07153588) |
| September 2, 2025 | NCT07149740 | Data Gathering for A10900 | Optos, PLC | Observational | Recruiting | Retinal Disease, Healthy, Glaucoma, Corneal Diseases | 180 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07149740) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| SpyGlass Pharma, Inc. | 5 | June 11, 2026 |
| Glaukos Corporation | 4 | September 14, 2026 |
| Stanford University | 4 | June 2, 2026 |
| Zagazig University | 3 | September 21, 2026 |
| Duke University | 3 | September 3, 2026 |
| Indiana University | 3 | August 14, 2026 |
| University of California, San Francisco | 3 | August 10, 2026 |
| Military Institute od Medicine National Research Institute | 3 | June 3, 2026 |
| Hôpital Privé de la Baie | 3 | April 15, 2026 |
| University of Miami | 2 | October 23, 2026 |
| Università degli Studi 'G. d'Annunzio' Chieti e Pescara | 2 | October 6, 2026 |
| Assiut University | 2 | September 25, 2026 |
| University Hospital, Bordeaux | 2 | September 3, 2026 |
| St. Joseph's Healthcare Hamilton | 2 | August 28, 2026 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 | August 20, 2026 |
| Benha University | 2 | August 10, 2026 |
| Universiti Sains Malaysia | 2 | August 3, 2026 |
| Kazakh Eye Research Institute | 2 | May 18, 2026 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 2 | May 12, 2026 |
| Center for Eye Research Australia | 2 | April 29, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 83 | November 5, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 50 | October 1, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 11 | October 23, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 7 | November 3, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 6 | March 27, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 4 | August 18, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 2 | June 11, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 2 | February 23, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | January 21, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 58 | November 3, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 7 | September 21, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 6 | October 6, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 6 | September 3, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 6 | August 28, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 6 | August 10, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 5 | September 17, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 5 | August 24, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 4 | June 3, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 3 | August 11, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 3 | June 29, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 3 | April 24, 2026 |
| [Singapore](https://specstream.ai/data/clinical-trials/country/singapore) | 3 | January 23, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 3 | January 7, 2026 |
| [Honduras](https://specstream.ai/data/clinical-trials/country/honduras) | 3 | September 4, 2025 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 2 | November 2, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 2 | August 18, 2026 |
| [Malaysia](https://specstream.ai/data/clinical-trials/country/malaysia) | 2 | August 3, 2026 |
| [Kazakhstan](https://specstream.ai/data/clinical-trials/country/kazakhstan) | 2 | May 18, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 2 | January 22, 2026 |
| [Armenia](https://specstream.ai/data/clinical-trials/country/armenia) | 2 | July 23, 2025 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 2 | June 11, 2025 |
| [Croatia](https://specstream.ai/data/clinical-trials/country/croatia) | 2 | May 14, 2025 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 2 | March 11, 2025 |
| [Norway](https://specstream.ai/data/clinical-trials/country/norway) | 1 | October 9, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).